Policy levers and delivery-system response
Evaluating provider and system response to regulatory, payment, and coverage changes.
Whether a coverage rule, regulatory waiver, or payment policy reshapes the delivery system depends on how providers respond. This thread examines provider and system response across changes including Medicaid Section 1115 SUD IMD waivers, Medicare's coverage of opioid treatment programs, COVID-era telehealth flexibilities for opioid use disorder, prior-authorization requirements, and crisis intervention teams — using physician surveys, descriptive evaluation, quasi-experimental designs, and policy commentary across the individual papers.
A central question across this thread is when provider behavior changes within existing facilities, and when access shifts because of facility entry and exit. The distinction has direct implications for how policy effects are estimated and for which levers translate into durable access gains. Recent difference-in-differences work finds that a substantial share of the access improvement under one Medicaid waiver came from facility opening and closure rather than incumbent practice change, with implications for how similar payment reforms are evaluated and projected. Policy designs and evaluations that ignore market entry and exit may under- or over-predict their own effects, an open question that motivates current work in this area.
Representative work
-
Medicaid: Increased Patient Access To MOUD In Residential Treatment Associated With Facility Openings And Closures, 2012–22
Difference-in-differences evaluation of Medicaid Section 1115 waivers and the share of access gains driven by facility entry and exit.
-
Is access to crisis teams associated with changes in behavioral health mortality?
County-level analysis linking changes in crisis-team access to changes in behavioral health mortality.
-
Access to Treatment Before and After Medicare Coverage of Opioid Treatment Programs
Evaluation of Medicare's coverage of opioid treatment programs and the gap between expanded enrollment access and ancillary service availability.
-
Physician Response to COVID-19-driven Telehealth Flexibility for Opioid Use Disorder
Survey of buprenorphine prescriber response to COVID-era telehealth flexibilities and physician demand for the policy changes that have since informed national telehealth policy.
-
Association of Access to Crisis Intervention Teams with County Sociodemographic Characteristics and State Medicaid Policies and Its Implications for a New Mental Health Crisis Lifeline
National mapping of crisis intervention team access on the eve of the 988 lifeline launch.
-
Buprenorphine Prior Authorization Removal: Low Hanging Fruit in the Opioid Overdose Crisis
Commentary on prior-authorization removal as an underused policy lever in the opioid overdose crisis.